SCHEMBL16269409

SCHEMBL16269409

O=C(O)N1CCc2cccc(O)c2C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 2/20 0.47
▸ DRD3 P35462 2/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ DRD5 P21918 1/20 0.47
▸ BCL2L1 Q07817 1/20 0.46
▸ BAD Q92934 1/20 0.46
▸ NOTUM Q6P988 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ ABHD6 Q9BV23 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ AKR1C3 P42330 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ TMEM97 Q5BJF2 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804587 0.87 AKR1C3 (0.50) DRD1DRD3DRD2DRD5BCL2L1
SCHEMBL17197242 0.85 NOTUM (0.63) DRD1DRD3DRD2DRD5BCL2L1
SCHEMBL3157303 0.84 HPGD (0.53) DRD1DRD3DRD2DRD5SMN1; SMN2
SCHEMBL16637906 0.84 TRAP1 (0.43) DRD1DRD3BCL2L1BADNOTUM
SCHEMBL30726807 0.83 ALDH1A1 (0.51) DRD2NOTUMMAPTMEN1KMT2A
SCHEMBL28182441 0.83 HPGD (0.44) NOTUMMAPTMEN1KMT2ATAAR1
SCHEMBL20564523 0.82 ABHD6 (0.60) DRD2NOTUMMAPTMEN1KMT2A
SCHEMBL13082466 0.82 CYP2D6 (0.51) DRD2NOTUMRAB9AAKR1C3AKR1C1
SCHEMBL13082467 0.82 RIPK1 (0.49) DRD2NOTUMMAPTMEN1KMT2A
SCHEMBL29118091 0.82 NOTUM (0.42) NOTUMMAPTMEN1KMT2ATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4139294-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4x Discovery Limited (GB) 2023-03-01 — — EP disclosed
CN-109890797-B Substituted carbon nucleoside derivatives useful as anticancer agents 辉瑞公司 2023-02-28 — — CN disclosed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 — — CN disclosed
WO-2021214470-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4X DISCOVERY LIMITED (GB) 2021-10-28 — — WO disclosed
CN-105263924-B Cxcr7 receptor modulators 爱杜西亚制药有限公司 2018-10-19 — — CN disclosed
EP-3004082-A1 CXCR7 RECEPTOR MODULATORS Actelion Pharmaceuticals Ltd. (CH) 2016-04-13 — — EP disclosed
WO-2014191929-A1 CXCR7 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2014-12-04 — — WO disclosed
Send feedback